Vanguard Group Inc. Has $99.01 Million Position in Proto Labs, Inc. $PRLB

Key Points

• Vanguard Group Inc. has reduced its stake in Proto Labs, selling 37,791 shares, and now holds 2,825,585 shares (11.89% ownership) valued at approximately $99 million.
• Research firms have recently upgraded Proto Labs' stock ratings, with Craig Hallum setting a target price of $54.00 and the consensus target price at $52.50.
• CEO Suresh Krishna purchased 1,725 shares at an average price of $43.51 per share, marking a significant increase in his ownership of the company's stock.

Vanguard Group Inc. decreased its stake in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 1.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,825,585 shares of the industrial products company's stock after selling 37,791 shares during the period. Vanguard Group Inc. owned 11.89% of Proto Labs worth $99,008,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of PRLB. LPL Financial LLC purchased a new position in shares of Proto Labs in the 4th quarter worth $210,000. Wells Fargo & Company MN boosted its holdings in Proto Labs by 23.3% in the fourth quarter. Wells Fargo & Company MN now owns 15,199 shares of the industrial products company's stock worth $594,000 after purchasing an additional 2,869 shares during the period. Bank of Montreal Can acquired a new stake in shares of Proto Labs during the 4th quarter worth approximately $274,000. Sterling Capital Management LLC grew its position in Proto Labs by 764.1% in the 4th quarter. Sterling Capital Management LLC now owns 795 shares of the industrial products company's stock worth $31,000 after purchasing an additional 703 shares during the last quarter. Finally, Barclays PLC increased its holdings in shares of Proto Labs by 4.1% during the fourth quarter. Barclays PLC now owns 44,393 shares of the industrial products company's stock valued at $1,735,000 after purchasing an additional 1,760 shares during the period. 84.54% of the stock is owned by institutional investors and hedge funds.

Proto Labs Price Performance

Shares of Proto Labs stock traded up $0.49 on Wednesday, hitting $50.59. 80,918 shares of the company's stock traded hands, compared to its average volume of 211,662. Proto Labs, Inc. has a one year low of $26.34 and a one year high of $51.09. The firm's 50-day moving average price is $42.55 and its two-hundred day moving average price is $39.36. The stock has a market capitalization of $1.21 billion, a PE ratio of 84.32 and a beta of 1.33.

Proto Labs (NYSE:PRLB - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The industrial products company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.08. Proto Labs had a net margin of 2.91% and a return on equity of 2.22%. The firm had revenue of $135.06 million for the quarter, compared to analyst estimates of $128.05 million. During the same period in the previous year, the business earned $0.38 EPS. The company's revenue was up 7.6% compared to the same quarter last year. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. On average, analysts forecast that Proto Labs, Inc. will post 0.81 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Proto Labs news, CEO Suresh Krishna acquired 1,725 shares of the business's stock in a transaction dated Monday, August 4th. The stock was bought at an average cost of $43.51 per share, with a total value of $75,054.75. Following the completion of the transaction, the chief executive officer directly owned 18,021 shares in the company, valued at approximately $784,093.71. This represents a 10.59% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.20% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on PRLB shares. Wall Street Zen upgraded Proto Labs from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 2nd. Craig Hallum raised Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 price target on the stock in a research report on Friday, August 1st. Finally, Cantor Fitzgerald increased their price target on shares of Proto Labs from $50.00 to $51.00 and gave the company an "overweight" rating in a report on Friday, August 1st. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $52.50.

About Proto Labs

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.